InvestorsHub Logo
Followers 144
Posts 27707
Boards Moderated 3
Alias Born 02/07/2004

Re: TechKim post# 164

Thursday, 03/30/2017 9:38:39 AM

Thursday, March 30, 2017 9:38:39 AM

Post# of 651

An ongoing Phase 2b trial is being conducted in collaboration with the UNISEC consortium. The research has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n°602012. Positive preliminary safety results were announced[1] in November 2016. BiondVax's consortium partners are continuing to analyze study samples. BiondVax expects the consortium will finalize and release results in Q2 2017.



Mind you TechKim, IMHO the Facility will not be built
before final approval!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y